procainamide Hydrochloride Injection, USP How Supplied/Storage and Handling
HOW SUPPLIED
Procainamide Hydrochloride Injection, USP is available in multiple-dose 10 mL vials providing 100 mg procainamide hydrochloride per mL and 2 mL vials providing 500 mg procainamide hydrochloride per mL.
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-1902-01 Case containing 25 cartons of 1 multiple-dose vial | 1 g/10 mL (100 mg/mL) |
| NDC 0409-1903-01 Bundle containing 25 cartons of 1 multiple-dose vial | 1 g/2 mL (500 mg/mL) |
The solutions, which are clear and colorless initially, may develop a slightly yellow color in time. This does not indicate a change which should preclude its use, but a solution any darker than light amber or otherwise discolored should not be used.
Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.]
Distributed by Hospira Inc., Lake Forest, IL 60045 USA
LAB-1321-3.0
Revised: 03/2021
Find procainamide Hydrochloride Injection, USPÂ medical information:
Find procainamide Hydrochloride Injection, USP medical information:
procainamide Hydrochloride Injection, USP Quick Finder
Health Professional Information
How Supplied/Storage and Handling
HOW SUPPLIED
Procainamide Hydrochloride Injection, USP is available in multiple-dose 10 mL vials providing 100 mg procainamide hydrochloride per mL and 2 mL vials providing 500 mg procainamide hydrochloride per mL.
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-1902-01 Case containing 25 cartons of 1 multiple-dose vial | 1 g/10 mL (100 mg/mL) |
| NDC 0409-1903-01 Bundle containing 25 cartons of 1 multiple-dose vial | 1 g/2 mL (500 mg/mL) |
The solutions, which are clear and colorless initially, may develop a slightly yellow color in time. This does not indicate a change which should preclude its use, but a solution any darker than light amber or otherwise discolored should not be used.
Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.]
Distributed by Hospira Inc., Lake Forest, IL 60045 USA
LAB-1321-3.0
Revised: 03/2021
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Report Adverse Event
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.